Bioequivalency Study of Sertraline Under Fed Conditions
Status:
Completed
Trial end date:
2003-07-01
Target enrollment:
Participant gender:
Summary
The objective of this study was the bioequivalence of a Roxane Laboratories' Sertraline
Tablets, 100 mg, to Zoloft® Tablets, 100 mg (Pfizer) under fed conditions using a
single-dose, 2-treatment, 2-period, crossover design.